Paul J Orchard
Paul J Orchard is an expert in Hematology at University of Minnesota (United States). As of October 2026, ScienceLeadR ranks Paul J Orchard in the top 1% of experts worldwide for Leukoencephalopathies, Adrenal Gland Diseases and Metabolism, Inborn Errors. Paul J Orchard has authored 398 publications, the most recent in 2026, and is an investigator in 18 clinical trials. SLR score: 1,199 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Genetics - Neurology - Transplantation
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1987 - 2026
Number : 398
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A Systematic Review of Metachromatic Leukodystrophy Newborn Screening: Transitioning from Pilot Studies to the Real World. PMID 42924763 — pilot projects, research design, genes, pilots, leukodystrophy, metachromatic, infant, newborn, neonatal screening, therapeutics, infant | Int J Neonatal Screen | 2026 | 0 |
| Metabolomic profiling in treated mucopolysaccharidosis IH reveals candidate biomarkers and adjunctive therapeutic pathways. PMID 42818411 — mucopolysaccharidoses, biomarkers, enzymes, metabolomics, therapeutics | medRxiv | 2026 | 0 |
| Biomarker changes in cerebral adrenoleukodystrophy after gene therapy or allogeneic hematopoietic cell transplant. PMID 42662429 — lysophosphatidylcholines, cells, genes, adrenoleukodystrophy, biomarkers, transplants, therapeutics | Mol Ther Adv | 2026 | 0 |
| Correction: Caregiver-reported disease burden in Krabbe disease: evaluating outcomes of hematopoietic stem cell transplantation. PMID 42638118 — cells, microscopy, electron, scanning transmission, rare diseases, hematopoietic stem cell transplantation, caregivers, stem cells, cost of illness, cell transplantation, stem cell transplantation, hematopoietic stem cells, transplantation, leukodystrophy, globoid cell | Orphanet J Rare Dis | 2026 | 0 |
| CSF GAG non-reducing ends in MPS IH after peripheral and brain-penetrating therapies: A model comparing IV non-targeted ERT and HCT. PMID 42137289 — blood-brain barrier, genes, gag, cells, heparitin sulfate, mucopolysaccharidoses, brain, biomarkers, enzyme replacement therapy, therapeutics | Mol Ther Adv | 2026 | 0 |
Clinical Studies 18
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map